MARTIN P. SUTTER - 15 Nov 2022 Form 4 Insider Report for ABIOMED INC

Role
Director
Signature
/s/ Marc A Began (by power of attorney)
Issuer symbol
N/A
Transactions as of
15 Nov 2022
Net transactions value
-$1,498,458
Form type
4
Filing time
17 Nov 2022, 15:05:39 UTC
Previous filing
17 Aug 2022
Next filing
27 Dec 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NASD Common Stock, $0.01 par value Sale $423,949 -1,133 -0.92% $374.18* 122,237 15 Nov 2022 Direct F1, F2
transaction NASD Common Stock, $0.01 par value Sale $325,059 -867 -0.71% $374.92* 121,370 15 Nov 2022 Direct F1, F3
transaction NASD Common Stock, $0.01 par value Sale $696,496 -1,859 -1.5% $374.66* 119,511 16 Nov 2022 Direct F1, F4
transaction NASD Common Stock, $0.01 par value Sale $52,954 -141 -0.12% $375.56* 119,370 16 Nov 2022 Direct F1, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Sale of common stock pursuant to reporting owner's 10b5-1 plan.
F2 This price represents the sale price of the transactions on the reported date at $374.1828. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
F3 This price represents the sale price of the transactions on the reported date at $374.9239. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
F4 This price represents the sale price of the transactions on the reported date at $374.6617. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
F5 This price represents the sale price of the transactions on the reported date at $375.5611. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.